Johnson & Johnson (JNJ) expands US footprint with more than USD 1bln investment in next generation cell therapy manufacturing facility in Pennsylvania

Johnson & Johnson's investment in a new cell therapy manufacturing facility emphasizes its commitment to growth and innovation within the pharmaceutical sector.

Newsquawk StaffPublished On the live feed at 4 more headlines followed before this page went public
Newsquawk headlinesUTC

Coinbase (COIN) CEO says Co. is buying cryptocurrency now when its down along with share buybacks, according to CNBC interview

Senator Moreno expects to get the Clarity Act passed by April, according to an interview with CNBC

Johnson & Johnson (JNJ) expands US footprint with more than USD 1bln investment in next generation cell therapy manufacturing facility in Pennsylvania

Phillip Morris (PM) expects average annual 2026-28 capex of USD 1.3-1.5bln and operating cash flow of about USD 45bln

Google (GOOGL) unveils its USD 499 pixel 10A smartphone, keeping the price unchanged

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
  • Facility will boost more than 4k construction jobs and 500 manufacturing jobs, while further strengthening the Co.'s annual USD 10bln economic impact across the state. 
Context

The creation of jobs and enhanced economic impact may positively influence local economies and reflect strong operational outlooks, potentially boosting stock performance and investor confidence in the sector. Watch for any implications this has on competitor strategies or market positioning in biotech.

Related headlines

The whole workspace, free to try.

Try it free